Filing Details
- Accession Number:
- 0001104659-22-123686
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-01 16:35:05
- Reporting Period:
- 2022-11-30
- Accepted Time:
- 2022-12-01 16:35:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1745020 | Theseus Pharmaceuticals Inc. | THRX | Pharmaceutical Preparations (2834) | 830712806 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1787307 | D. Bradford Dahms | C/O Theseus Pharmaceuticals, Inc. 314 Main Street Cambridge MA 02142 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-11-30 | 1,502 | $6.66 | 6,142 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The price reported is a weighted average price of shares purchased. These shares were purchased in multiple transaction at prices ranging from $6.56 to $6.70, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.
- Includes 1,162 shares and 1,508 shares previously purchased under the Issuer's 2021 Employee Stock Purchase Plan on May 13, 2022 and November 14, 2022, respectively.
Billionaire Hedge Funds
